DIVD.US Altrius Global Dividend ETF
- Total assets
- 27.7M
- Expense ratio
- 0.47%
- Dividend yield
- 2.78%
- 1-year return
- +26.16%
- Holdings
- 63
- Since
- 2022
Fund data as reported by the issuer, updated Nov 13, 2026. Total assets are in the fund's base currency.
What does DIVD.US invest in?
- Mostly Non-US stocks (50.4%)
- Largest sector: Healthcare (21.1%)
- Largest region: North America (54.0%)
- Top 3 holdings: 7.4% of the fund
Asset allocation
- Non-US stocks 50.4%
- US stocks 50.0%
- Cash 0.7%
- Other 0.2%
Top holdings
- Toyota Motor Corporation ADR 2.57%
- NXP Semiconductors NV 2.42%
- AstraZeneca PLC 2.37%
- British American Tobacco p.l.c. 2.30%
- Roche Holding Ltd ADR 2.30%
Altrius Global Dividend ETF performance
Sharpe ratio 1.30- This year
- +21.43%
- 1 year
- +26.16%
- 3 years
- +20.88%
- 5 years
- -
Volatility 12.8% over 1 year and 12.2% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DIVD.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Altrius Global Dividend ETF
To pursue its objective, the fund will invest at least 90% of its net assets, plus the amount of any borrowings for investment purposes, in dividend-paying equity securities. The principal type of equity security in which the fund will invest is common stock. Under normal market conditions, at least 30% of the fund"s assets will be invested outside the United States.
Full fund profileAltrius Global Dividend ETF top holdings
22.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Toyota Motor Corporation ADR TM.US | Consumer Cyclical | United States | 2.57% |
| NXP Semiconductors NV NXPI.US | Technology | United States | 2.42% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 2.37% |
| British American Tobacco p.l.c. BTI.US | Consumer Defensive | United States | 2.30% |
| Roche Holding Ltd ADR RHHBY.US | Healthcare | United States | 2.30% |
| Muenchener Rueckver Ges MURGY.US | Financial Services | United States | 2.27% |
| Capgemini SE ADR CGEMY.US | Technology | United States | 2.22% |
| Sanofi ADR SNY.US | Healthcare | United States | 2.20% |
| Novartis AG ADR NVS.US | Healthcare | United States | 2.15% |
| Nestle SA ADR NSRGY.US | Consumer Defensive | United States | 2.14% |
The 10 largest of 63 holdings.
DIVD.US sector exposure
- Healthcare21.1%
- Financial Services19.5%
- Consumer Defensive19.0%
- Industrials11.2%
- Energy6.4%
- Technology6.3%
- Consumer Cyclicals5.8%
- Basic Materials5.5%
- Communication Services3.3%
- Real Estate1.0%
Share of the stocks in the fund.
DIVD.US regional exposure
- North America54.0%
- Europe Developed28.6%
- United Kingdom12.9%
- Japan2.6%
- Latin America1.9%
Share of the stocks in the fund.
Company size
Average market cap 105B- Mega cap37.3%
- Big cap40.1%
- Medium cap15.5%
- Small cap4.0%
Altrius Global Dividend ETF fund profile
- Fund name
- Altrius Global Dividend ETF
- Ticker
- DIVD.US
- Exchange
- USA Stocks
- Issuer
- Altrius Capital Management,Inc.
- Index tracked
- -
- Category
- Global Equity
- Inception date
- Sep 29, 2022
- Trading currency
- USD
- Expense ratio
- 0.47%
- Annual turnover
- 0.1%
About Altrius Global Dividend ETF
To pursue its objective, the fund will invest at least 90% of its net assets, plus the amount of any borrowings for investment purposes, in dividend-paying equity securities. The principal type of equity security in which the fund will invest is common stock. Under normal market conditions, at least 30% of the fund"s assets will be invested outside the United States.